Two new classes of experimental drugs shown to have powerful muscle-building capabilities–selective androgen receptor modulators (SARMs) and myostatin inhibitors–have been added to the World Anti-Doping Agency’s (WADA) list of prohibited substances for 2008.
I believe that there is nothing wrong with safe muscle enhancement. Unlike steroids it will improve the health of most of those who use it. Preventing deterioration of muscle in the elderly. There are some people have the activated genes which causes myostatin inhibition and there is no indication that their health is bad or that their life expectency is less.
IGF-1 LR3 Benefits:
Stimulates muscle growth and has been shown to benefit the heart (a muscle).
Encourages the absorption of Chondroitin Sulfate and Glucosamine Sulfate (also found in Velvet Antler).
Regenerates nerve tissue
Helps burn fat, increase protein transport into cells, and reduce protein breakdown
Improves the production of white blood cells
Decreases LDL Cholesterol
So to recap, IGF-1 provides almost permanent muscle-creating, muscle-repairing, and anti-aging benefits.
In 2004 the leading experts on the subject admitted that this gene therapy could already be in use, and that the technology and knowledge is such that the process to deliver it isn’t complicated.
Back in 2002, University of Pennsylvania gene therapy researcher Lee Sweeney studied ways to treat muscular dystrophy and the general frailty that comes with aging. In his lab, he inserted a gene called IGF-1 into the muscles of mice. The IGF-1 gene effect is being mimicked by the new myostatin inhibitors.
“The good this can bring to people with muscle disease and the elderly far outweighs the potential downside from an athletic standpoint,” he says, “so I think it’s going to have to be dealt with.”
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.